Infant Botulism

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Infant Botulism trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT00004401

Study of Human Botulism Immunoglobulin in Infants With Botulism

OBJECTIVES: I. Determine the safety of human botulism immune globulin (BIG) in patients with infant botulism by monitoring side effects (e.g., rash, fever, hypo…

United States120 participantsStarted 1998-01

Treatment: botulism immune globulin